GDRX vs IDXX · P/E 49, rev $394.4M vs P/E 40, rev $2.36B
Goodrx Holdings Inc (GDRX) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Goodrx Holdings Inc (GDRX) is a health information services company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported GDRX revenue for 2026-06-30 was $394.4M. Net income was $9.7M. GDRX currently screens at market cap $988.9M and trailing P/E 48.7.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
GDRX currently screens at market cap $988.9M and trailing P/E 48.7. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the GDRX and IDXX stock pages for the full models.
Not investment advice.